We evaluated the DiscovErr system, in which we had previously implemented a new methodology for assessment of compliance to continuous application of evidence-based clinical guidelines, based on a bidirectional search from the guideline objectives to the patient's longitudinal data, and vice versa. We compared the system comments on 1584 transactions regarding the management, over a mean of 5.23 years, of 10 randomly selected Type 2 diabetes patients, to those of two diabetes experts and a senior family practitioner. After providing their own comments, the experts assessed both the correctness (precision) and the importance of each of the DiscovErr system comments. The completeness (recall or coverage) of the system was computed by comparing its comments to those made by the experts. The system made 279 comments. The experts made 181 unique comments. The completeness of the system was 91% compared to comments made by at least two experts, and 98% when compared to comments made by all three. 172 comments were evaluated by the experts for correctness and importance: All 114 medication-related comments, and a random 35% of the 165 monitoring-related comments. The system's correctness was 81% compared to comments judged as correct by both diabetes experts, and 91% compared to comments judged as correct by a diabetes expert and at least as partially correct by the other. 89% of the comments were judged as important by both diabetes experts, 8% were judged as important by one expert, 3% were judged as less important by both experts. The completeness scores of the three experts (compared to the comments of all experts plus the validated system comments) were 75%, 60%, and 55%; the experts' correctness scores (compared to their majority) were respectively 99%, 91%, and 88%. Conclusion: Systems such as DiscovErr can assess the quality of continuous guideline-based care.
|Original language||English GB|
|State||Published - 16 Mar 2021|